Anpario’s (ANP) “House Stock” Rating Reaffirmed at Shore Capital

Anpario (LON:ANP)‘s stock had its “house stock” rating reaffirmed by research analysts at Shore Capital in a report released on Monday,Digital Look reports.

Separately, Canaccord Genuity Group increased their price target on Anpario from GBX 500 to GBX 550 and gave the company a “buy” rating in a report on Tuesday, October 21st. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, Anpario presently has a consensus rating of “Buy” and a consensus price target of GBX 550.

Anpario Stock Up 9.4%

Shares of Anpario stock traded up GBX 44.50 during trading on Monday, hitting GBX 516. 105,467 shares of the stock traded hands, compared to its average volume of 27,871. The stock has a market cap of £87.44 million, a P/E ratio of 17.36 and a beta of 0.58. Anpario has a twelve month low of GBX 286 and a twelve month high of GBX 536.50. The company has a fifty day moving average price of GBX 488.29 and a two-hundred day moving average price of GBX 459.09. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.